Millions of patients’ lives are improved every day because of advancements in medical technology. But too often, gaps in coverage and access prevent patients from benefiting from the safe, effective,…
BOSTON, MA, UNITED STATES, May 26, 2026 /EINPresswire.com/ — UltraSight™, a leader in AI-guided cardiac imaging, today announced publication of a multicenter peer-reviewed study in European Heart Journal – Digital…
BOSTON, MA, UNITED STATES, May 19, 2026 /EINPresswire.com/ — UltraSight™, a leader in AI-guided cardiac imaging, today announced the appointment of Rick Geoffrion as Chairman of the Board. Mr. Geoffrion…
Learn how AdvaMed’s standards are shaping innovation and improving regulatory efficiency across the medical technology industry.
WASHINGTON—AdvaMed® announced today that nominations for its 2025 Lifetime Achievement Award as well as the AdvaMedDx Lifetime of Leadership & Service Award and theAdvaMed® Imaging Röntgen Award are open through April 10. All three of these…
TORONTO and DALLAS, March 3, 2026 /PRNewswire/ – Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTCQX: PYNKF) (“Perimeter” or the “Company”), a commercial-stage medical technology company, announced today that it has received U.S.…
WASHINGTON, D.C.—AdvaMed, the world’s largest trade association representing medical technology innovators, announced that its Medical Device Submissions Workshop Series (February 23-27 in Washington, D.C.) has been officially approved for RAC…
In a new video developed in partnership with Patients Rising, AdvaMed’s Peter Weems, Vice President of Imaging Government Affairs and Policy Strategy, explains why the Health Tech Investment Act is critical to expanding patient…
WASHINGTON, D.C.—AdvaMed, the MedTech Association®, today announced that Rich Fabian, president and CEO of FUJIFILM Sonosite, will serve as the chair of the Medical Imaging division’s board of directors. He will succeed David Pacitti, CEO of Avanos Medical and former president and…
WASHINGTON, D.C.—AdvaMed, the MedTech Association®, today announced Michael “Mick” Farrell, chairman and CEO of Resmed Inc. (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing, and care delivered in…